Methyl mercury influences growth-related signaling in MCF-7 breast cancer cells

Environmental Toxicology

Volumn 20, Issue 1, 2005, Pages 32-44

  Sukocheva, Olga A ^a   Yang, Yi ^b   Gierthy, John F ^b,c   Seegal, Richard F ^b,c  

^a HANSON INSTITUTE   (Australia)

^b WADSWORTH CENTER   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Ca2+; Erk1 2; Estrogen; Estrogen receptor; MCF 7 breast cancer cells; Methyl mercury

Indexed keywords

CELLS; CHEMICAL ACTIVATION; ENVIRONMENTAL IMPACT; ENZYMES; IMPURITIES; TUMORS;

BREAST CANCER; ENVIRONMENTAL CONTAMINANTS; METHYL MERCURY; PHOSPHORYLATION;

MERCURY (METAL);

CALCIUM; ESTRADIOL; ESTROGEN RECEPTOR; METHYLMERCURY; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RALOXIFENE; METHYLMERCURY DERIVATIVE;

CANCER;

ARTICLE; BREAST CANCER; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CANCER CELL; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESTROGEN METABOLISM; GROWTH STIMULATION; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; FEMALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

MINK CELL FOCUS-FORMING VIRUS;

BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; METHYLMERCURY COMPOUNDS; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 19544393238     PISSN: 15204081     EISSN: None     Source Type: Journal    
DOI: 10.1002/tox.20075     Document Type: Article

References (47)

1. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J-A, Nilsson S. 1998. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol Pharmacol 54:105-112.
2. Bemis JC, Seegal RF. 2000. Polychlorinated biphenyls and methylmercury alter intracellular calcium concentrations in rat cerebellar granule cells. Neurotoxicology 21:1123-1134.
3. Blair AMJN, Clark B, Clarke AJ, Wood P. 1975. Tissue concentrations of mercury after chronic dosing of squirrel monkeys with Thimerosal. Toxicology 3:171-176.
4. Boffetta P, Merler E, Vainio H. 1993. Carcinogenicity of mercury and mercury compounds. Scand J Work Environ Health 19(1): 1-7.
5. 2+ spikes in HeLa cells by sensitizing the inositol 1,4,5-trisphosphate receptor. J Biol Chem 267:25113-25119.
6. Caron GA, Poutala S, Provost TT. 1970. Lymphocyte transformation induced by inorganic and organic mercury. Int Arch Allergy Appl Immunol 37(1):76-87.
7. Chetty CS, Rajanna S, Hall E, Yallapragada PR. Rajanna B. 1996. In vitro and in vivo effects of lead, methyl mercury and mercury on inositol 1,4,5-trisphosphate and 1,3,4,5-tetrakisphosphate receptor bindings in rat brain. Toxicol Lett 87:11-17.
8. Clarkson TW. 2002. The three modern faces of mercury. Environ Health Perspect 110(1):11-23.
9. De Flora S, Bennicelli C, Bagnasco M. 1994. Genotoxicity of mercury compounds. A review. Mutat Res 317:57-79.
10. Delnomdedieu M, Allis JW. 1993. Interaction of inorganic mercury salts with model and red cell membranes: importance of lipid binding sites. Chem Biol Inter 88:71-87.
11. Driggers PH, Segars JH. 2002. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 13:422-427.
12. 2+ response amplitude and duration. Nature 386:855-858.
13. Gierthy JF, Lincoln DWI, Roth KE, Bowser SS, Bennett JA, Bradley L, Dickerman HW. 1991. Estrogen-stimulation of post-confluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J Cell Biochem 45:177-187.
14. Gierthy JF, Arcaro KF, Floyd M. 1997. Assessment of PCB estrogenicity in a human breast cancer cell line. Chemosphere 34:1495-1505.
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
16. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100(1):57-70.
17. Hultman P, Hansson-Georgiadis H. 1999. Methyl Mercury-Induced Autoimmunity in Mice, Toxicol Appl Pharmacol 154: 203-211.
18. Hyder SM, Chiappetta C, Murthy L, Stancel GM. 1997. Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Res 57:2547-2549.
19. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP. 1999. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 96:4686-4691.
20. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494.
21. Lukes AJ, Kosti NM. 1992. Disproportionation involving an organomercurial and a sulfhydryl-containing protein. Reaction between chloromercuryferrocene and bakers'-yeast cytochrome c. J Inorg Biochem 46:77-85.
22. Lund BO, Miller DM, Woods JS. 1992. Mercury-induced H2O2 production and lipid peroxidation in vitro in rat kidney mitochondria. Biochem Pharmacol 42:S181-S187.
23. Malaguti C, Yasumoto T, Paolo Rossini G. 1999. Transient Ca2+-dependent activation of ERK1 and ERK2 in cytotoxic responses induced by maitotoxin in breast cancer cells. FEBS Lett 458(2):137-140.
24. Martin MB, Reiter R, Pham T, Avellanet YR, Camara J, Lahm M, Pentecost E, Pratap K, Gilmore BA, Divekar S, Dagata RS, Bull JL, Stoica A. 2003. Estrogen-like activity of metals in MCF-7 breast cancer cells. Endocrinology 144:2425-2436.
25. Marty MS, Atchison WD. 1997. Pathways mediating Ca2+ entry in rat cerebellar granule cells following in vitro exposure to methyl mercury. Toxicol Appl Pharmacol 147:319-330.
26. Mason MJ, Garcia-Rodriguez C, Grinstein S. 1991. Coupling between intracellular Ca2+ stores and the Ca2+ permeability of the plasma membrane. Comparison of the effects of thapsi-gargin, 2,5-di-(tert-butyl)-1,4- hydroquinone, and cyclopiazonic acid in rat thymic lymphocytes. J Biol Chem 266:20856-20862.
27. Moss RL, Gu Q, Wong M. 1997. Estrogen: nontranscriptional signaling pathway. Recent Prog Horm Res 52:33-68.
28. Murata M, Gong P, Suzuki K, Koizumi S. 1999. Differential metal response and regulation of human heavy metal-inducible genes. J Cell Physiology 180:105-113.
29. Musgrove EA, Sutherland RL. 1994. Cell cycle control by steroid hormones. Semin Cancer Biol 5:381-389.
30. Nishida E, Gotoh Y. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18(4):128-131.
31. Ortega HG, Lopez M, Takaki A, Huang QH, Arimura A, Salvaggio JE. 1997. Neuroimmunological effects of exposure to methylmercury forms in the Sprague-Dawley rats. Activation of the hypothalamic-pituitary-adrenal axis and lymphocyte responsiveness. Toxicol Ind Health 13(1):57-66.
32. Pessah IN, Feng W. 2000. Functional role of hyperreactive sulfhydryl moieties within the ryanodine receptor complex. Antioxid Redox Signal. 2(1):17-25.
33. Poulin R, Merand Y, Poirier D, Levesque C, Dufour JM, Labrie F. 1989. Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells. Breast Cancer Res Treat 14:65-76.
34. Pu MY, Akhand AA, Kato M, Koike T, Hamaguchi M, Suzuki H, Nakashima I. 1996. Mercuric chloride mediates a protein sulfhydryl modification-based pathway of signal transduction for activating Src kinase, which is independent of the phosphorylation/dephosphorylation of a carboxyl terminal tyrosine. J Cell Biochem 63(1):104-114.
35. Rosenspire AJ, Bodepudi S, Mathews M, McCabe MJ Jr. 1998. Low levels of ionic mercury modulate protein tyrosine phosphorylation in lymphocytes. Int J Immunopharmacol 20:697-707.
36. Salama G, Abramson JJ, Pike GK. 1992. Sulphydryl reagents trigger Ca2+ release from the sarcoplasmic reticulum of skinned rabbit psoas fibres. J Physiol 454:389-420.
37. Segars JH, Driggers PH. 2002. Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes. Trends Endocrinol Metab 13:349-354.
38. Shanker G, Aschner M. 2003. Methylmercury-induced reactive oxygen species formation in neonatal cerebral astrocytic cultures is attenuated by antioxidants. Brain Res Mol Brain Res 110(1):85-91.
39. Spink DC, Eugster HP, Lincoln DW. 2nd, Schuetz JD, Schuetz EG, Johnson JA, Kaminsky LS, Gierthy JF. 1992. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch Biochem Biophys 293:342-348.
40. Sonnenschein C, Soto AM. 1998. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol 65(1-6): 143-150.
41. 2-Terminal Kinase Activity, and Apoptosis. Mol Cel Biol 19:5659-5674.
42. Sukocheva OA, Wang L, Albanese N, Pitson SM, Vadas MA, Xia P. 2003. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol Endocrinol 17:2002-2012.
43. Tabata M, Kumar Sarker A, Nyarko E. 2003. Enhanced conformational changes in DNA in the presence of mercury(II), cadmium(II) and lead(II) porphyrins. J Inorg Biochem 94(1-2):50-58.
44. Tchounwou PB, Ayensu WK, Ninashvili N, Sutton D. 2003. Environmental exposure to mercury and its toxicopathologic implications for public health. Environ Toxicol 18(3): 149-175.
45. Thuvander A, Sundberg J, Oskarsson A. 1996. Immunomodulating effects after perinatal exposure to methylmercury in mice. Toxicology. 114(2): 163-175.
46. Watson CS, Pappas TC, Gametchu B. 1995. The other estrogen receptor in the plasma membrane: implications for the actions of environmental estrogens. Environ Health Perspect. 103(7):41-50.
47. Whitekus MJ, Santini RP, Rosenspire AJ, McCabe MJ Jr. 1999. Protection against CD95-mediated apoptosis by inorganic mercury in Jurkat T cells. J Immunol. 162:7162-7170.